Literature DB >> 9076509

Chemical synthesis of Haemophilus influenzae glycopeptide conjugates.

A A Kandil1, N Chan, M Klein, P Chong.   

Abstract

A simple procedure for conjugating synthetic fragments of the capsular polysaccharide of Haemophilus influenzae type b, poly-3-beta-D-ribose-(1,1)-D-ribitol-5-phosphate (sPRP) to linear peptides is described. The procedure consists of (i) reacting the amino group of amino-heptyl sPRP with m-maleimidobenzoyl-N-hydroxysuccinimide (MBS) in phosphate buffer, pH 7.5; (ii) selectively coupling the MBS-modified sPRP to the sulfhydryl group of the cysteine residue of peptides containing functional T-helper cell epitope(s). The glycopeptide conjugates were purified by gel filtration chromatography, biochemically characterized, and elicited protective level of anti-PRP antibody responses in rabbits.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9076509     DOI: 10.1023/a:1018500712733

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  21 in total

Review 1.  Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine.

Authors:  B Fritzell; S Plotkin
Journal:  J Pediatr       Date:  1992-09       Impact factor: 4.406

2.  Reassessment of Ellman's reagent.

Authors:  P W Riddles; R L Blakeley; B Zerner
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

3.  Molecular conservation of the P6 outer membrane protein among strains of Haemophilus influenzae: analysis of antigenic determinants, gene sequences, and restriction fragment length polymorphisms.

Authors:  M B Nelson; R S Munson; M A Apicella; D J Sikkema; J P Molleston; T F Murphy
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

4.  Identification of surface-exposed B-cell epitopes recognized by Haemophilus influenzae type b P1-specific monoclonal antibodies.

Authors:  H Panezutti; O James; E J Hansen; Y Choi; R E Harkness; M H Klein; P Chong
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

5.  Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination.

Authors:  T V Murphy; K E White; P Pastor; L Gabriel; F Medley; D M Granoff; M T Osterholm
Journal:  JAMA       Date:  1993-01-13       Impact factor: 56.272

6.  Effect of neonatal immunization with diphtheria and tetanus toxoids on antibody responses to Haemophilus influenzae type b conjugate vaccines.

Authors:  J M Lieberman; D P Greenberg; V K Wong; S Partridge; S J Chang; C Y Chiu; J I Ward
Journal:  J Pediatr       Date:  1995-02       Impact factor: 4.406

Review 7.  Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines.

Authors:  D M Granoff; M H Rathore; S J Holmes; P D Granoff; A H Lucas
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

8.  Prospects for prevention of Haemophilus influenzae type b disease by immunization.

Authors:  D M Granoff; R S Munson
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

9.  National trends in Haemophilus influenzae meningitis mortality and hospitalization among children, 1980 through 1991.

Authors:  K C Schoendorf; W G Adams; J L Kiely; J D Wenger
Journal:  Pediatrics       Date:  1994-04       Impact factor: 7.124

Review 10.  Synthetic peptide representing a T-cell epitope of CRM197 substitutes as carrier molecule in a Haemophilus influenzae type B (Hib) conjugate vaccine.

Authors:  G S Bixler; R Eby; K M Dermody; R M Woods; R C Seid; S Pillai
Journal:  Adv Exp Med Biol       Date:  1989       Impact factor: 2.622

View more
  2 in total

1.  A strategy for rational design of fully synthetic glycopeptide conjugate vaccines.

Authors:  P Chong; N Chan; A Kandil; B Tripet; O James; Y P Yang; S P Shi; M Klein
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

2.  A gold nanoparticle-linked glycoconjugate vaccine against Burkholderia mallei.

Authors:  Anthony E Gregory; Barbara M Judy; Omar Qazi; Carla A Blumentritt; Katherine A Brown; Andrew M Shaw; Alfredo G Torres; Richard W Titball
Journal:  Nanomedicine       Date:  2014-09-03       Impact factor: 5.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.